Bako Diagnostics News
BakoDx Begins Testing Novel Coronavirus Samples
ATLANTA — Bako Diagnostics has expanded its molecular test portfolio to meet the U.S. need for the novel coronavirus testing, with results completed in [...]
The Importance of Testing for Onychodystrophy
Dr. Tracey Vlahovic discusses the importance of sending nail specimens for laboratory testing. To download your copy of the nail specimen collection guide, click [...]
DNA-based Onychomycosis Detection Correlates Better to Histopathology than does Fungal Culture
Onychomycosis is a prevalent disease of the nail. Traditional methods for diagnosis include direct microscopy with potassium hydroxide (KOH microscopy) and fungal [...]
APMAPAC honors Bako Diagnostics with Champion of 2019 Award
BakoDx has served the podiatric medical community for the past 10 years and has shown a deep dedication and passion for the profession. [...]
Bako Diagnostics Announces Tracey C. Vlahovic, DPM, Joins Podiatric Medical Advisory Board
ATLANTA — Bako Diagnostics is pleased to announce that Tracey C. Vlahovic, DPM, has joined its Podiatric Medical Advisory Board. Dr. Vlahovic is a [...]
BakoDx Announces Naghmeh Lilly Khavari, DPM, as Clinical Consultant
Dr. Naghmeh Lilly Khavari ATLANTA — Feb. 7, 2019 — BakoDx is pleased to welcome Dr. Naghmeh Lilly Khavari to its Clinical [...]
BakoDx continues all five national health plan provider relationship in 2019
ATLANTA — Jan. 24, 2019 — Bako Diagnostics continues its strong in-network laboratory status with all five national health plans into 2019. Members covered [...]
Bako Diagnostics is Honored to Support the Podiatric Medical Community
ATLANTA — Jan. 4, 2019 — In 2018, Bako Diagnostics (BakoDx) continued a long tradition of supporting the podiatric medical community. These efforts and [...]
Bako Diagnostics and StrataDx Announce a Strategic Relationship. The Parent Company of Bako Diagnostics, the Leading U.S. Podiatry-focused Pathology Laboratory, has Acquired StrataDx, a Leading Laboratory Focused on Dermatopathology and Oral Pathology
ATLANTA/BOSTON—October 10, 2018— Bako Diagnostics and StrataDx announce a strategic relationship. The parent company of Bako Diagnostics has acquired StrataDx, a leading U.S. dermatopathology [...]
Bako Diagnostics Expands Clinical Utility of Nail Dystrophy Assay
ATLANTA — July 11, 2018 — Bako Diagnostics (BakoDx), the leader in nail dystrophy diagnostic testing, announced the availability of its expanded molecular test [...]
Bako Diagnostics Announces the Formation of Its Podiatric Advisory Board
ATLANTA. Feb. 26, 2018 – Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced today that they have formed a Podiatric Advisory Board [...]
Bako Diagnostics Announces Appointments to Clinical Consultant Team – Podiatry Faculty
ATLANTA. Feb. 26, 2018 – Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced appointments to the Bako Clinical Consultant Team. This Team [...]
Bako Launches New Website for the Podiatric Community – bakodx.com
Company changes name to Bako Diagnostics and redesigns logo to reflect increased clinical laboratory services for podiatrists ATLANTA. Dec. 15 /PRNewswire/ - Bako, [...]